Gene · 7376
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipid metabolism in homeostasis and disease. | Signal Transduct Target Ther | 2026 | 41692800 | PubTator, text mining | PubMed |
| Insights Into circRNA-Mediated Lipid Metabolism in Cancer Progression. | J Cell Mol Med | 2026 | 41652992 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts (CAFs) derived from MFAP2 promote CRC proliferation and metastasis while suppressing CD8+ T cell-mediated antitumor immunity. | Cell Death Dis | 2026 | 41617683 | PubTator, text mining | PubMed |
| Immune pathways and prenatal/perinatal environmental exposures contribute to epigenetic gestational age prediction and acceleration. | Epigenetics | 2026 | 41557483 | PubTator, text mining | PubMed |
| The LXRβ/NF-κB axis reprograms CAR-T cells to resist exhaustion in the tumor microenvironment. | Oncoimmunology | 2026 | 41496523 | PubTator, text mining | PubMed |
| Identification and characterization of anti-NAFLD peptides from fish maw using in silico analysis, molecular docking, and DFT quantum calculation. | Food Chem | 2026 | 41478094 | PubTator, text mining | PubMed |
| Liver X receptors and the hallmarks of aging: From molecular mechanisms to therapeutic opportunities. | Ageing Res Rev | 2026 | 41314477 | PubTator, text mining | PubMed |
| Liver X receptor: A potential target for inflammatory bowel disease and colorectal cancer (Review). | Mol Med Rep | 2026 | 41312741 | PubTator, text mining | PubMed |
| Gene-Level Analyses of Novel Olfactory-Related Signal from Severe SARS-CoV-2 GWAS Reveal Association with Disease Mortality. | COVID | 2025 | 41836198 | PubTator, text mining | PubMed |
A therapeutic approach of LC-MS characterised MFER-Mc against alcohol and NDEA induced hepatocellular carcinoma activity through LXR-α, LXR-β and HMG-CoA pathway: an in-silico, in-vitro and in-vivo study. | Med Oncol | 2025 | 41455855 | PubTator, text mining | PubMed |
| Bioactive Glycosylated Flavonoids Exhibiting LXR Agonist Activity from a Lauraceae Colombian Species. | Plants (Basel) | 2025 | 41225791 | PubTator, text mining | PubMed |
| Bioinformatics analysis of TCGA data identifies a taurine metabolism-related subtype classification for predicting prognosis in colon adenocarcinoma. | J Gastrointest Oncol | 2025 | 41220730 | PubTator, text mining | PubMed |
| Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target. | Front Cell Dev Biol | 2025 | 41041664 | PubTator, text mining | PubMed |
| A new serological autoantibody signature associated with multiple sclerosis. | Neurobiol Dis | 2025 | 41038542 | PubTator, text mining | PubMed |
| In search of nonlipogenic ABCA1 inducers (NLAI): precision coregulator TR-FRET identifies diverse signatures for LXR ligands. | bioRxiv | 2025 | 41000830 | PubTator, text mining | PubMed |
| Diesel particulate matter-induced proteomic changes in three-dimensional spheroids derived from human primary cells of various tissue origins. | Sci Rep | 2025 | 40993169 | PubTator, text mining | PubMed |
| mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport. | Mol Cell | 2025 | 40972529 | PubTator, text mining | PubMed |
| The paradoxical effects of 7-Ketocholesterol and TO901317 on LPS-induced inflammation in human retinal pigment epithelium cells. | Biochem Biophys Res Commun | 2025 | 40957321 | PubTator, text mining | PubMed |
| Cellular cholesterol metabolism rewiring through SREBP2-LXR-mTOR signaling convergence orchestrates T cell fate and keratinocyte apoptosis in oral lichen planus. | Int Immunopharmacol | 2025 | 40957169 | PubTator, text mining | PubMed |
| Maladaptive trained immunity in viral infections. | J Clin Invest | 2025 | 40892509 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7376/papers?page=2